drugset / Trial / NCT01665599

A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel

NCT01665599

Phase 3 Completed 180 enrolled Ferring Pharmaceuticals
NaSingle-groupOpen-labelTreatment

Summary

This is a Phase 3 clinical trial in adult hypogonadal males with baseline serum testosterone concentrations \<300 ng/dL. The purpose of this study is to evaluate the safety and efficacy of testosterone gel (2%) delivered using an applicator.

Timeline

Start
2012-07
Primary completion
2013-04
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule 46 mg Topical

Indications